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Introduction
Globally, chronic pain is a leading cause of long-term disability 
with an estimated one in five adults experiencing moderate-to-severe 
pain [1]. According to consensus guidelines, chronic pain remains 
under-diagnosed and under-treated even in many advanced nations 
[1]. Data on chronic pain in Asia are particularly scarce, although local 
studies from Singapore and Hong Kong have reported an estimated 
prevalence of 8.7% and 10.8%, respectively [2,3]. Chronic pain arising 
from non-malignant sources referred to as chronic non-cancer pain 
(CNCP), most commonly manifests in the form of musculoskeletal 
pain, headache, neck/lower back pain, osteoarthritis, neuropathy and 
fibromyalgia [4]. The overall treatment goal for CNCP is not only 
the control of pain, but also the restoration of each patient’s physical 
and emotional functioning to improve quality of life (QoL). Due to 
the diverse etiological factors that cause CNCP, management of the 
condition is often complex and may include either focused therapy or 
a comprehensive integration of various therapeutic strategies. Clinical 
trials for opioid use in CNCP have yielded controversial outcomes. In 
some studies of patients who have been well-characterized with CNCP, 
greater consideration of opioid use has been recommended [5-7]. 
However, other comprehensive studies have found that the evidence is 
insufficient to determine the effectiveness of long-term opioid therapy 
for improving chronic pain and function (Chou, Turner, et al. Ann 
Intern Med 17; 162(4): 276-86)). Clinical guidelines advocate opioid use 
only when the benefits outweigh the perceived risks [8-10]. Although 
opioids have been reported as effective in reducing pain scores in short-
term trials involving osteoarthritis and neuropathic pain, a high rate 
of discontinuation owing to adverse effects has been observed in some 
of these trials [11-13]. A number of policy makers are consequently 
emphasizing the importance of clinical expertise, proper medical 
education and caution when prescribing opioids [8]. Several issues have 
been documented that appear to complicate pain management practices 
in Asia including cultural beliefs, a lack of awareness, tight regulations, 
and accessibility problems which are partially influenced by regional 
history, especially in China [14].” Although the clear identification 
Abstract
Background: The objective of the ACHEON survey was to investigate current practices in chronic non-cancer 
pain (CNCP) management in Asia, with a focus on opioid use. 
Methods: A questionnaire-based survey conducted in 10 Asian countries/regions was answered by 695 physicians 
managing pain (median experience: 15 years) and 1,305 patients experiencing CNCP within the preceding 3 months. 
Results: Overall, 89.3% of patients reported experiencing moderate-to-severe pain (median pain duration of 
24 months). Continuing pain management education of ≤10 hours was reported by 71.1% of the physicians. While 
approximately 80% of physicians reported quantifying pain in practice, 65.0% of patients reported that no scale was 
used for their pain assessment. A significant proportion of physicians (78%) perceived discordance between their 
patients’ actual pain level and their own evaluation. Opioids were considered necessary for CNCP management by 
63.6% of physicians. However, while non-opioid oral medication was prescribed to 66.8% of patients, only 4.4% of 
patients were prescribed opioids. CNCP was reported to affect activities of daily living for 80.8% of patients. Physician-
perceived barriers to optimal therapy included patients’ reluctance to use opioids owing to fear of adverse effects 
(65.0%) and addiction (64.9%), while physicians’ reluctance to prescribe opioids (63.7%) was partially attributable to 
inadequate pain assessment (60.9%) and excessive regulation of opioids (57.3%). 
Conclusion: While the majority of patients surveyed reported moderate-to-severe CNCP, opioid use was 
suboptimal. Physician and patient education to address stigmas associated with opioid use may improve pain 
management practices in these countries. 
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all aspects of the survey were included. Patients who were employees 
or related to employees of healthcare, pharmaceutical, advertising or 
market research companies, or those involved in any other studies 
investigating pain treatments were excluded. Patients were contacted 
via patient-patient or doctor referral, hospital intercepts, phone book 
or door-to-door recruitment, online panel, and via patient associations. 
The percentage of patients contacted via each method for each 
corresponding country/region has been listed in Supplementary File 3.
Questionnaires 
The questionnaires for the physician and patient surveys were 
developed by a Steering Committee of 16 specialists managing pain 
across the participating countries. The questions for physicians 
addressed demographic parameters (including age, sex, years in 
practice, specialization and types of on-going training), clinical 
practice concerning the screening and assessment of pain, and clinical 
practice concerning the management of pain. The questions for 
patients included demographic data (including age, sex, numerical 11 
point box [BS-11] pain scores, duration of pain and type/location of 
pain), screening and assessment of pain, perception of doctors’ attitude 
towards pain, treatment, and the effect of pain on activities of daily 
living including work and employment status. The questionnaire was 
subsequently translated into the local languages of the participating 
countries – Traditional Chinese (Hong Kong, Taiwan), simplified 
Chinese (China, Malaysia and Singapore), Korean, Bahasa Malaysian, 
Tagalog (Philippines), Thai, Vietnamese, and Bahasa Indonesian. 
Survey method
Informed consent was obtained from all physicians included in the 
study, following initial contact via telephone or a face-to-face meeting 
in which a description of the research was provided. Subsequently, 
telephone or face-to-face interviews were scheduled. For patients, 
informed consent was obtained in the patient disclosure section of the 
questionnaire which was administered either as a web-based link or on 
paper.
Data analysis
A numeric rating scale (NRS) from 0 to 10 was used to evaluate 
physicians’ attitudes and clinical practice patterns including screening, 
assessment, and optimization of CNCP management with a focus on 
opioid analgesics. The responses were evaluated using the following 
categories: NRS score >5 (high), representing adequacy or agreement, 
NRS score=5, considered neutral and NRS score <5 (low), indicating 
inadequacy or disagreement. Subsequently, these categorized 
scores were calculated as a percentage of all respondents. Median 
(interquartile range [IQR]) scores were calculated for descriptive data, 
where applicable. The questionnaire for patients included statements 
with “yes” or “no” responses or a 5 point Likert rating scale from “agree 
completely” to “disagree completely”. Statistics were analyzed using 
SPSS Version 16.0 (SPSS Software, Chicago, IL, USA)
Results
Characteristics of physicians and patients
The demographic characteristics of the 695 physicians and 1,305 
patients that completed the CNCP survey are presented in Table 1a and 
1b, respectively. Physicians included in the survey had been involved 
in professional practice for a mean duration of 15 years. Orthopedists 
and general physicians comprised 49.3% of the sample, while 17.3% of 
those included were pain management specialists or anesthesiologists 
(Table 2). For physicians, the response rate ranged from 6.8% in Hong 
of these issues is challenging, such efforts are critical for improving 
standards of patient care. With this aim, the ACHEON Working Group 
comprising 16 international experts sought to investigate the attitudes 
and perceptions of physicians and patients towards pain management 
across 10 Asian countries and regions.
Methods
Survey design
Physicians and patients were recruited from 10 countries and regions 
in Asia including China, Hong Kong, Indonesia, the Republic of Korea, 
Malaysia, the Philippines, Singapore, Taiwan, Thailand and Vietnam. 
The selected participants were surveyed anonymously over a period of 
4 months from September to December 2013. This questionnaire-based 
study did not involve any form of clinical intervention, and therefore 
ethical approval was not deemed necessary. The survey was conducted 
in accordance with guidelines stipulated by the European Society for 
Opinion and Market Research (ESOMAR) [15]. Key ESOMAR criteria 
that were met to ensure ethical survey conduct included conformation 
to all national and international laws, maintenance of physician and 
patient confidentiality, voluntary cooperation by all respondents 
following provision of adequate information regarding the project, 
assurance that the data would not be used for any other purposes, as 
well as an objective study design and transparent reporting of project 
activities. The lists of hospitals used in each country/region for survey 
recruitment can be viewed as Supplementary File 1. All patients and 
physicians were remunerated for their participation in the survey.
Objectives of the survey
The primary objective of ACHEON was to investigate current 
practices in CNCP management from the perspective of both physicians 
and patients. The study assessed physicians’ attitudes toward pain 
management and their prescribing habits, particularly with regards to 
opioids, while patients were asked about their current pain levels, type 
of pain, attitude towards pain and treatment satisfaction levels. The 
effect of pain on overall patient QoL was evaluated by determining its 
impact on activities of daily living, sleeping patterns, concentration and 
focus, reliance on others, work, and employment status.
Selection of physicians
Physicians were eligible for the study if they were managing CNCP 
in a professional setting, were involved in the direct care of patients with 
CNCP, and were willing to participate in all aspects of the study. Names 
were randomly selected from official databases provided by physician 
organizations, national registries, official societies or other organizations 
as deemed appropriate by the Steering Committee. The primary 
treatment types for the selected physicians included pharmacological 
agents, interventional treatment, surgical techniques, and/or alternative/
holistic treatment. Physicians who were employed by or affiliated with 
a pharmaceutical company were excluded from the survey. There was 
significant variability between the countries/regions in terms of the most 
common specialities involved in the survey, but overall, the top 3 specialties 
were (in order) General Practitioner, Orthopaedist/Orthopaedic Surgery 
and Pain/ANE (Supplementary File 2).
Selection of patients
Patients aged ≥18 years (>20 years for Korean and Taiwanese 
patients) with a documented history of CNCP in the preceding 3 months 
were recruited through patients’ associations, doctor referrals, hospital 
intercepts, online sources, patient referrals, door-to-door recruitment 
and phone book recruitment. Those willing and able to participate in 
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1a: Demographic characteristics of physician respondents managing CNCP (n=695)
Parameters
Median (IQR)
Age, years 44 (12)
Gender n (%)
Female 182 (26.2)
Male 513 (73.8)
Country/region n (%)
Republic of Korea 125 (17.9)
China 100 (14.4)
Malaysia 70 (10.1)
Indonesia 70 (10.1)
Thailand 70 (10.1)
Hong Kong 60 (8.6)
Singapore  50 (7.2)
Philippines 50 (7.2)
Taiwan 50 (7.2)
Vietnam 50 (7.2)
Years in clinical practice n (%)
1-5 58 (8.4)
6-10 154 (22.2)
11-15 168 (24.2)
16-20 159 (22.8)
>21 156 (22.4)
IQR, interquartile range; CNCP, chronic non-cancer pain
1b: Demographic characteristics of patients completing the survey (n=1,305)
Parameters
Median (IQR)
Age, years 48 (18) 
Gender n (%)
Female 794 (60.8)
Male 511 (39.2)
Country/region n (%)
China 250 (19.2)
Republic of Korea 250 (19.2)
Philippines 125 (9.6)
Singapore 102 (7.8)
Malaysia 102 (7.8)
Vietnam 101 (7.7)
Hong Kong 100 (7.7)
Indonesia 100 (7.7)
Thailand 100 (7.7)
Taiwan 75 (5.6)
BS-11 pain score n (%)
Severe (7-10) 586 (44.9)
Moderate (4-6) 579 (44.4)
Mild (0-3) 140 (10.7)
Median (IQR)
BS-11 pain score 6.0 (2.0)
Duration of pain n (%)
More than 1 year 817 (62.6)
<6 months to 1 year 205 (15.7)
3-6 months 283 (21.7)
Median (IQR)
Months of pain experienced 24 (39)
BS-11; Numerical 11 point box; IQR, interquartile range; CNCP, chronic non-cancer pain
Table 1: Demographic characteristics of the survey participants
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Kong to 54.7% in Indonesia, while for patients, it ranged from 5.2% in 
Hong Kong to 69% in the Philippines. For multi-country surveys of 
this size, it remains challenging to control for response rates between 
countries, due to factors such as cultural differences and the diverse 
nature of physician-patient relationships.
Patients included in the survey reported experiencing CNCP 
for a median duration of 24 months (IQR=39 months). Notably, 
78.3% (n=1,022) of patients had pain lasting more than 6 months. 
Furthermore, 89.3% (n=1,165/1,305) of patients were experiencing 
moderate-to severe pain with a median score of 6 (IQR=2) on the BS-
11 pain scale (Table 1b). The most common locations of pain reported 
were the head/neck and feet/knees/legs, while arthritis and poor posture 
were identified as the primary causes of pain (Figures 1a and 1b).
One third of physicians report inadequate medical school 
training on opioid use
A significant percentage of physicians (71.1%, n=494) reported 
receiving ≤10 hours of continuing medical education (CME) training 
on CNCP management in the past year (Figure 2). A total of 31.5% 
(n=219) of physicians described their medical school training on opioid 
use as inadequate.
Disparities exist between physician and patient-reported 
screening and assessment of CNCP
The majority of physicians diagnosed CNCP by assessing medical/
surgical histories, as well as conducting physical examinations that 
included neurological and musculoskeletal evaluation. Pain was 
reportedly routinely characterized and/or quantified by 89.1% (n=619; 
median [IQR], 8 [2]) and 79.6% (n=553; median [IQR], 8 [3]) of 
physicians, respectively. Quantitative tools such as visual analogue 
Area of expertise Number of physicians (%)
Orthopedists 173 (24.8)
General practitioners 170 (24.5)
Pain specialists/anesthesiologists 120 (17.3)
Rheumatologists 107 (15.4)
Geriatricians/neurologists/endocrinologists 95 (13.7)
Internal medicine 20 (2.9)
Rehabilitative specialists 10 (1.4)
Table 2: Distribution of physicians by area of expertise (n=695).
 
Figure 1a: Most common locations of pain reported by patients 
(n=1,305). Respondents were able to select more than 1 response.
Figure 1b: Causes of pain reported by patients (n=1,129; patients were 
consulted on the probable source of their pain by their physicians). 
*Headache refers to migraine, tension and cluster headaches. 
**Neuropathy (e.g., diabetic neuropathy). Respondents were able to select 
more than 1 response.
Figure 2: Hours of continuing medical education (focused on pain) 
received over the prior 12 months (n=695).
scales, BS-11 or the FACES pain rating scale were used by 77% (n=535) 
of physicians. However, 65% (n=848) of patients reported that no scale 
was used by their physicians for pain quantification (Figure 3). The 
inadequate assessment of pain by physicians and/or nurses was also 
recognised as a barrier to optimal pain management by 60.9% (n=423) 
of the physicians themselves. Overall, 77.6% (n=1,012) of patients had 
never been referred to a pain specialist or pain clinic. Pain specialists 
were responsible for managing pain in only 8.6% (n=112) of patients. 
Possible reasons identified by the physicians for not referring their 
patients to a pain clinic included the likelihood of pain specialists 
recommending undesirable interventional procedures for pain 
treatment (41.9%, n=291), difficulty in arranging appointments with 
pain specialists (36.7%, n=255) and a lack of pain clinics in their region 
(35.1%, n=244).
Evidence for suboptimal use of opioids in CNCP management
Opioid treatment was deemed necessary for the treatment of CNCP 
by 63.6% (n=442) of physicians, and 79.4% (n=552) agreed that no single 
opioid was optimal for all patients. Among the 1,305 patients assessed, 
1,093 were receiving treatment for pain at the time of the survey. Of 
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Figure 3: Discordance between physicians (n=695) and patients (n=1305) 
reporting quantitative pain assessment in practice.
those who could recall their specific form of pharmacotherapy, 66.8% 
(n=730) were prescribed non-opioid analgesics or non-steroidal anti-
inflammatory drugs; however, opioid prescriptions were received 
by only 4.4% (n=48) of these patients (Table 3a). A list of side effects 
occurring with the use of pain medications is presented in Table 3b.
Barriers to optimization of therapy remain
A reluctance by patients to take opioid therapies due to fear of 
adverse effects (65.0%, n=452) and fear of addiction (64.9%, n=451) 
were identified as key barriers, while 63.7% (n=443) of physicians 
admitted their own reluctance to prescribe opioids was a barrier. A total 
of 57.3% (n=398) of physicians pointed out that excessive regulations 
on opioid drugs hindered the optimization of treatment. Table 4 
summarizes these findings.
Pain significantly impacts QoL and activities of daily living 
The majority of physicians (90.4%, n=628/695) and patients 
receiving treatment (78.9%, n=862/1093) answered that the impact 
of pain on QoL was routinely evaluated. However, 77.4% (n=538) of 
physicians noted discordance between the patients’ pain assessment and 
their own assessment. Pain affected the activities of daily living in 80.8% 
(n=1,054) of patients, including disruption of sleeping patterns (80%, 
n=843), and concentration and focus (79.4%, n=837). Overall, less than 
half of the patients surveyed (47.6%, n=502) reported having a relatively 
good QoL (Table 5). A total of 803 (61.5%) patients who responded 
were employed at the time of the survey. Of these, 503 (62.6%) stated 
that their performance at work was disrupted due to their chronic 
pain. Only 62.5% (n=683) of patients claimed to be satisfied with their 
current pain treatment.
Discussion
The ACHEON survey recruited a total of 695 physicians and 1,305 
patients from 10 Asian countries and regions to determine perceptions 
toward CNCP management in routine clinical practice. 89.3% of 
patients surveyed reported suffering from moderate-to-severe pain 
lasting for a median duration of 24 months. The negative impact of this 
3a: Medications prescribed to patients for pain relief (n=1093)
Type of medication* Number of patients (%)
Non-opioids
Analgesics and NSAIDs 730 (66.8)
Muscle relaxants 265 (24.3)
Sedative/sleeping pills 128 (11.7)
Antidepressants 64 (5.9)
Anticonvulsants 36 (3.3)
Opioids 48 (4.4)
Traditional Chinese medicine 99 (9.1)
Herbal medicine 66 (6.0)
Others 54 (4.9)
None of the above 94 (8.6)
*Patients were able to select more than one response NSAID, non-steroidal 
anti-inflammatory drugs
3b: Adverse events experienced due to current pain medication (n=1093)
Adverse event* n (%) of patients
Sleepiness/Drowsiness 241 (22.1)
Tiredness 175 (16.0)
Dizziness/giddiness 154 (14.1)
Nausea/ Vomiting 124 (11.3)
Constipation 92 (8.4)
Anxiety (worry)/ depression 69 (6.3)
Swelling (mostly of the feet or other 
extremities) 63 (5.8)
Itchiness in skin 62 (5.7)
Abdominal pain 55 (5.0)
Tremor 46 (4.2)
Diarrhea (loose bowel movements) 36 (3.3)
Difficulty in passing urine 25 (2.3)
None 505 (46.2)
*Patients were able to select more than 1 response
Table 3: Treatment options prescribed for pain relief and adverse events 
experienced by patients (n=1093).
Potential barrier
Number of 
physicians (%) 
(NRS >5)
Median 
(IQR)
Patient’s aversion to take opioids due to fear of 
adverse effects 452 (65.0) 7.0 (3.0)
Patient’s aversion to take opioids due to fear of 
addiction 451 (64.9) 6.0 (3.0)
Physicians reluctance to prescribe opioids 443 (63.7) 6.0 (3.0)
Inadequate assessment of pain by physicians and/
or nurses 423 (60.9) 6.0 (3.0)
Limitations of non-opioid analgesics 401 (57.7) 6.0 (4.0)
Excessive regulations of opioid drugs 398 (57.3) 6.0 (3.0)
Lack of pain or palliative medicine services 353 (50.8) 6.0 (4.0)
Patient’s reluctance to report pain 327 (47.1) 5.0 (5.0)
Patient’s inability to pay for interventional 
analgesics/pharmacological treatment/opioid 
analgesics
 308 (44.3) 5.0 (4.0)
Table 4: Potential barriers to optimizing CNCP management from the perspective 
of the physicians interviewed (n=695).
pain on activities of daily living was apparent in the majority of patient 
respondent, yet only 62.5% of patients indicated satisfaction with 
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their treatment. Although the majority of physicians were generally 
knowledgeable about CNCP management and opioid use, significant 
gaps were evident in clinical practice. Opioid use was confirmed in 4.4% 
of patients, regardless of pain severity. In comparison to usage rates in 
the EU and North America, this is relatively low, and may be indicative 
of a reluctance to prescribe opioid therapy. However, the possibility 
remains that these opioid usage rates may have been underestimated 
owing to some patients being unaware of their medication type. 
Aversion to opioid use by patients due to fears of adverse effects and 
addiction was identified as a primary barrier. These observations 
are in line with previous studies that have highlighted the stigmas 
associated with opioid use [8,13,16-18]. It has been established that 
barriers to optimizing pain management are generally higher for Asian 
patients when compared to their Western counterparts, which further 
exacerbates the challenges of alleviating CNCP in Asia [19]. Over half 
of the physicians noted that excessive regulations on opioids were 
obstacles to their prescription. Strict regulations are known to influence 
physicians into modifying their prescribing patterns and resorting to 
therapies with fewer regulatory barriers, as well as lower doses and/
or lower prescription durations [20]. Drug misuse and adverse effects 
are undoubtedly major concerns for opioid therapy; however, careful 
patient selection, adherence to recommended prescription guidelines 
and competent monitoring are effective tools that can mitigate 
these associated risks [21]. Ongoing medical training is essential for 
physicians to accurately prescribe safe and effective opioid therapy. In 
this survey, 31.5% of physicians felt that their medical school training 
was inadequate, with the majority reporting ≤10 hours of CME focused 
on CNCP pain management. It has been reported that early education 
on pain management improves patient-focused care while increasing 
preparedness for pain management [22]. A greater provision of these 
programs represents a key measure that is likely to improve the quality 
of CNCP management in Asia. The accurate identification of pain 
using a thorough pain assessment protocol is essential for patients to 
receive optimal opioid therapy [21,23]. However, discordance between 
physician- and patient-reported pain assessment protocols was 
observed in this survey. The majority of physicians reported routinely 
quantifying pain, but 65% of patients claimed that no scale had been 
used for their assessment. A reflection of this observation was noted in 
the physicians’ survey as well, recognizing the inadequate assessment 
of pain as a barrier to optimal treatment by 60.9% of physicians, with 
77.4% suspecting differences between their professional assessment 
and the actual levels of pain experienced by their patients. Although 
the physician-patient relationships could not be completely matched in 
this survey, these findings are indicative of a significant deficiency in 
clinical practice that warrants further evaluation. . 
Our findings suggest that many physicians are hesitant to refer 
patients to specialized pain clinics. Although primary care physicians 
may be considered adept at managing co-morbidities, the intervention 
of pain management specialists may provide a more accurate diagnosis 
of pain and therefore more effective therapeutic outcomes. In a robust 
healthcare system, pain specialist clinics are an integral component 
of multidisciplinary pain management programmes, and are more 
effective at assessing individual patient needs [24,25]. Evidence-based 
research from the Pain Association of Singapore Task Force echoes 
the importance of these multidisciplinary teams for the effective 
administration of opioid therapy [26,27]. Earlier reports suggest 
that approximately 90% of patients visiting pain management clinics 
are prescribed narcotics; however, the rate of opioid prescriptions by 
primary care physicians is evidently much lower [28]. Primary care 
physicians may not have easy access to opioids due to unavailability and 
local regulations, and may lack the necessary education and training for 
safe opioid administration. Hence, understanding current practices is 
necessary to promote a more widespread adoption of effective treatment 
systems. However, there are also real and very serious risks associated 
with long-term opioid therapy, such as death. In parts of North America, 
this problem has exacerbated to such an extent that it has been referred 
to as an epidemic. There clearly therefore needs to be a very cautious 
and balanced approach to opioid prescription, in which benefits and 
risks are carefully understood We note several limitations to our 
findings due to the subjective nature of this questionnaire-based survey. 
It was not practical to ensure uniformity of recruitment methods across 
the individual countries, and all patients who reported CNCP within 
the previous 3 months and were willing to participate were eligible for 
inclusion. Furthermore, it remains likely that some patient groups were 
not identified and therefore omitted from the analysis. However, to the 
best of our knowledge, our findings represent the first significant survey 
to provide broad insight on current CNCP management practices in 
Asia. Our survey demonstrates that a significant number of patients 
are living with CNCP of moderate-to-severe intensity that significantly 
impacts their QoL. A greater prioritization of evidence-based outcomes 
in pain management through collaborative efforts between physicians, 
patients, regulatory bodies and the pharmaceutical industry is needed 
for more effective patient care.
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